A premarket piece for developer adherence gives providers peace of mind about the safety of the products they're using and a ...
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...
White supremacist Thomas Ryan Rousseau must pay court costs and never touch UVa Grounds again, but he will serve no time ...
Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $17.66 which represents a slight increase of $0.53 or 3.09% from the prior close of $17.13. The stock opened at $17.55 and ...
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...
Global investment manager Oaktree is out with its third life sciences-dedicated special purpose acquisition company after ...
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the struggling drugmaker to make changes to turn its performance around, [The Wall Street Journal reported]( ...
The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...
Friday’s jobs report could bolster the view that the American economy is holding steady, but an oil price shock could ...
The company has been doing incredibly well, and revenue as well as profits have skyrocketed in recent quarters. Shares of ...
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...